Aretex Capital Partners Announces Sale of its Interest in Surgical Specialties Corporation to Corza Health
Aretex Capital Partners today announces that it has sold its interest in Surgical Specialties Corporation (‘SSC’) to GTCR-owned Corza Health.
SSC is a leading, diversified medical device manufacturer of branded, private label and OEM products. The company, headquartered in Westwood, MA, has worldwide operations, and produces high quality specialty surgical consumables for over 50 years. The terms of the transaction were not disclosed.
A consortium led by ZQ Capital Limited and Vivo Capital LLC acquired SSC in 2017. In addition to Aretex Capital Partners, which acquired its stake in July 2018, the consortium also included China Orient Asset Management (International) Holding Limited, Fung Shing Investments Ltd, FS KKR Capital Corp, Cathay Venture Inc. and Nan Fung Group.
Aretex Capital Partner’s investment in SSC marks the first complete exit since its inception in 2018.
Sergio D’Angelo and Andrew Feller, managing partners at Aretex Capital Partners said: “We have enjoyed working with the SSC management team and the consortium of investors over the past two and- a-half years. The successful sale of SSC marks our first exit since creating Aretex Capital Partners in 2018, and we are especially pleased with the business delivering significant growth and expanding its customer footprint with high quality product offerings internationally over the consortium’s ownership period.”
Aretex Capital Partners is a global private equity firm focused on investments primarily in Europe and North America. Aretex works in partnership with entrepreneurs and management teams with a proven track record of success and seeks to create value by helping businesses drive sustainable growth and access international markets. Launched in 2018, Aretex maintains offices in London and New York.
For further information, visit www.aretexcapital.com.